China NMPA Product Recall - Medical Angiography X-ray System

Philips Medical Systems Nederland B.V., through its subsidiary Philips (China) Investment Co., Ltd., initiated a voluntary Level III recall of its Medical Angiography X-ray systems. The recall was publicly announced on October 18, 2024. The primary reason for this action was the discovery of inconsistencies in the technical data presented in the product instructions and associated technical documents for these medical devices. This issue necessitated the recall to ensure product information accuracy and compliance. The recall affects specific registered medical device models (e.g., 20203060323, 20193060314, etc.) within the Chinese market, although certain models, specifications, and batches were not imported into China. This action falls under the regulatory oversight of the National Medical Products Administration (NMPA) of China. The company is required to manage the recall process, including providing detailed information in a "Medical Device Recall Event Report Form," to address the identified discrepancies and maintain regulatory standards.